Informationen:
Fehler:
ID
29815
Beschreibung
The Effects of Two Days of Bedrest on Insulin Resistance in Type 2 Diabetics; ODM derived from: https://clinicaltrials.gov/show/NCT00508599
Link
https://clinicaltrials.gov/show/NCT00508599
Stichworte
Versionen (1)
- 21.04.18 21.04.18 - Julian Varghese
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
21. April 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Type 2 Diabetes NCT00508599
Eligibility Type 2 Diabetes NCT00508599
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Type 2 Diabetes NCT00508599
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Non-Insulin-Dependent Diabetes Mellitus disease length
Item
type 2 diabetic for at least 6 months.
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0872146 (UMLS CUI [1,2])
Healthy Volunteers
Item
healthy volunteers.
boolean
C1708335 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | insulin secretion | C-peptide measurement
Item
type 2 diabetic subjects will have some nominal ability to secrete endogenous insulin as demonstrated by a post-stimulation c-peptide concentration of at least 6 ng/ml.
boolean
C0011860 (UMLS CUI [1])
C1256369 (UMLS CUI [2])
C0202100 (UMLS CUI [3])
C1256369 (UMLS CUI [2])
C0202100 (UMLS CUI [3])
Informed Consent
Item
all subjects will be mentally fit to give informed consent.
boolean
C0021430 (UMLS CUI [1])
Glucohemoglobin measurement
Item
hemoglobin a1c value below 11% (normal range = 4.4-5.8%) prior to study enrollment.
boolean
C0202054 (UMLS CUI [1])
Glycosylated haemoglobin increased
Item
hemoglobin a1c values > 11%
boolean
C0019018 (UMLS CUI [1])
Cardiovascular Disease Severe | Liver disease Severe | Kidney Disease Severe
Item
severe cardiovascular, hepatic, or renal disease
boolean
C0007222 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0022658 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0205082 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0022658 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Substance Use Disorders
Item
past current history of drug or alcohol abuse
boolean
C0038586 (UMLS CUI [1])
Gastroparesis due to diabetes mellitus
Item
diabetic gastroparesis
boolean
C0267176 (UMLS CUI [1])
Uncontrolled hypertension
Item
uncontrolled hypertension ( > 140-90 mmhg)
boolean
C1868885 (UMLS CUI [1])
Hyperlipidemia Marked | serum LDL | Serum thyroglobulin level
Item
marked hyperlipidemia (serum ldl > 158mg/dl, or serum tg >691 mg/dl)
boolean
C0020473 (UMLS CUI [1,1])
C1706089 (UMLS CUI [1,2])
C0036816 (UMLS CUI [2])
C1271701 (UMLS CUI [3])
C1706089 (UMLS CUI [1,2])
C0036816 (UMLS CUI [2])
C1271701 (UMLS CUI [3])
Pharmaceutical Preparations Interfere with Glucose homeostasis
Item
medications that interfere with glucose homeostasis
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C1326961 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,2])
C1326961 (UMLS CUI [1,3])
Coumadin | Anticoagulants
Item
coumadin or other anticoagulation medications
boolean
C0699129 (UMLS CUI [1])
C0003280 (UMLS CUI [2])
C0003280 (UMLS CUI [2])
Thrombosis | Thrombophlebitis
Item
history of thrombosis or thrombophlebitis
boolean
C0040053 (UMLS CUI [1])
C0040046 (UMLS CUI [2])
C0040046 (UMLS CUI [2])
Malignant Neoplasms
Item
current malignancy
boolean
C0006826 (UMLS CUI [1])
Tobacco use
Item
smoker
boolean
C0543414 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Contact precautions
Item
contact precautions
boolean
C1443873 (UMLS CUI [1])